Geri
Inhibikase Therapeutics Inc (IKT) Fiyatı
IKT Hisse Senedi Fiyat Grafiği
IKT Kazanmak
Inhibikase Therapeutics Inc
$1.67
1.82%
$0.03
Kapanışta: Feb 13, 16:00:00 GMT-5
$1.65
-1.19%
$-0.02
Sonrası Piyasa: Feb 13, 20:00:00 GMT-5
Önemli İstatistikler
Önceki Kapanış
$1.64
Açılış fiyatı
$1.64
Günün Aralığı
$1.64 - $1.73
52 haftalık aralık
$1.33 - $3.32
İşlem hacmi
218.2K
Ort.Hacim
449.4K
EPS (TTM)
-1.15
Dividend yield
--
Piyasa Değeri
$199.4M
IKT nedir?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.